Graceway Pharmaceuticals, LLC
Graceway Pharmaceuticals, LLC, a prominent player in the pharmaceutical industry, is headquartered in the United States. Founded in 2006, the company has established itself as a key provider of innovative healthcare solutions, focusing primarily on dermatology and other specialty areas. With a commitment to developing high-quality prescription medications, Graceway Pharmaceuticals has achieved significant milestones, including the successful launch of several unique products that address unmet medical needs. The company’s core offerings include topical treatments and therapies that stand out for their efficacy and safety profiles. Graceway's dedication to research and development has positioned it as a trusted name in the market, earning recognition for its contributions to patient care. With a strong operational presence across the US and beyond, Graceway Pharmaceuticals continues to strive for excellence in delivering effective healthcare solutions.
DitchCarbon Score
How does Graceway Pharmaceuticals, LLC's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Graceway Pharmaceuticals, LLC's score of 30 is higher than 54% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Graceway Pharmaceuticals, LLC's reported carbon emissions
Graceway Pharmaceuticals, LLC, headquartered in the US, currently does not have publicly available carbon emissions data for the most recent year, nor specific reduction targets or initiatives outlined in their climate commitments. Without concrete emissions figures or defined reduction strategies, it is challenging to assess their environmental impact or progress in addressing climate change. In the pharmaceutical industry, companies are increasingly recognising the importance of sustainability and are often encouraged to set science-based targets for emissions reductions. While Graceway Pharmaceuticals has not disclosed specific commitments or targets, the industry context suggests a growing trend towards transparency and accountability in carbon management. As the company moves forward, it may consider establishing measurable goals to reduce its carbon footprint, aligning with broader industry standards and expectations for climate action.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Graceway Pharmaceuticals, LLC is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
